Article

Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer.

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Molecular and Cellular Biology (Impact Factor: 5.04). 09/2010; 30(17):4159-74. DOI: 10.1128/MCB.00235-10
Source: PubMed

ABSTRACT Previous studies have shown that tumor progression in the transgenic adenocarcinoma of mouse prostate (TRAMP) model is characterized by global DNA hypomethylation initiated during early-stage disease and locus-specific DNA hypermethylation occurring predominantly in late-stage disease. Here, we utilized Dnmt1 hypomorphic alleles to examine the role of Dnmt1 in normal prostate development and in prostate cancer in TRAMP. Prostate tissue morphology and differentiation status was normal in Dnmt1 hypomorphic mice, despite global DNA hypomethylation. TRAMP; Dnmt1 hypomorphic mice also displayed global DNA hypomethylation, but were characterized by altered tumor phenotype. Specifically, TRAMP; Dnmt1 hypomorphic mice exhibited slightly increased tumor incidence and significantly increased pathological progression at early ages and, conversely, displayed slightly decreased tumor incidence and significantly decreased pathological progression at advanced ages. Remarkably, hypomorphic Dnmt1 expression abrogated local and distant site macrometastases. Thus, Dnmt1 has tumor suppressor activity in early-stage prostate cancer, and oncogenic activity in late stage prostate cancer and metastasis. Consistent with the biological phenotype, epigenomic studies revealed that TRAMP; Dnmt1 hypomorphic mice show dramatically reduced CpG island and promoter DNA hypermethylation in late-stage primary tumors compared to control mice. Taken together, the data reveal a crucial role for Dnmt1 in prostate cancer and suggest that Dnmt1-targeted interventions may have utility specifically for advanced and/or metastatic prostate cancer.

Download full-text

Full-text

Available from: Adam Karpf, Feb 21, 2014
0 Followers
 · 
140 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We are addressing the problem of Euclidean reconstruction with an uncalibrated affine camera and the calibration of this camera. We investigate constraints under which the Euclidean shape and motion problem becomes linear. The theoretical study described in this paper leads us to impose some practical constraints that the camera is mounted onto a robot arm and that the robot is executing controlled motions whose parameters are known. The affine camera model considered here is just an approximation of the true projective mapping. Nevertheless, there is a large number of applications for which the camera is allowed to be at some distance from the scene and under these circumstances the affine model is a good approximation. The fact that we deal with an uncalibrated camera is an advantage over previous methods because we do not rely any more on the tedious task of camera calibration. The experimental results obtained show that the method described compares favourably with other similar methods
    Intelligent Robots and Systems, 1997. IROS '97., Proceedings of the 1997 IEEE/RSJ International Conference on; 10/1997
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We analyze the transmission response of symmetric multiple phase-shifted long-period fiber gratings (LPGs). In particular, we present the optimal design parameters for two and three phase-shifted LPGs having a flat-top passband response. Similarities and differences between symmetric multiple phase-shifted LPGs and fiber Bragg gratings (FBGs) are highlighted.
    Optics Communications 05/2002; 205(4-6):271-276. DOI:10.1016/S0030-4018(02)01363-9 · 1.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Three active DNA (cytosine-5) methyltransferases (DNMTs) have been identified in mammalian cells, Dnmt1, Dnmt3a, and Dnmt3b. DNMT1 is primarily a maintenance methyltransferase, as it prefers to methylate hemimethylated DNA during DNA replication and in vitro. DNMT3A and DNMT3B are de novo methyltransferases and show similar activity on unmethylated and hemimethylated DNA. DNMT3L, which lacks the catalytic domain, binds to DNMT3A and DNMT3B variants and facilitates their chromatin targeting, presumably for de novo methylation. There are several mechanisms by which mammalian cells regulate DNMT levels, including varied transcriptional activation of the respective genes and posttranslational modifications of the enzymes that can affect catalytic activity, targeting, and enzyme degradation. In addition, binding of miRNAs or RNA-binding proteins can also alter the expression of DNMTs. These regulatory processes can be disrupted in disease or by environmental factors, resulting in altered DNMT expression and aberrant DNA methylation patterns.
    Progress in molecular biology and translational science 01/2011; 101:311-33. DOI:10.1016/B978-0-12-387685-0.00009-3 · 3.11 Impact Factor